Medicare Enrolled
Dr. Paul Mefferd, D.O.
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mefferd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mefferd?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mefferd
Dr. Paul Mefferd is a pain medicine physician in Marietta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mefferd performed 3,304 Medicare services across 1,444 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mefferd received a total of $3,445 from 45 pharmaceutical and/or device companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mefferd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in GA
$3,445 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,304
Medicare services
Top 26% in GA for pain medicine (physical medicine & rehabilitation) physician
1,444
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
875 | $62 | $457 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
733 | $60 | $249 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
648 | $112 | $458 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
101 | $68 | $662 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
98 | $0 | $4 |
| Injection, methylprednisolone acetate, 40 mg | 71 | $6 | $38 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
69 | $1 | $4 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
68 | $148 | $627 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $79 | $656 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
59 | $94 | $1,447 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
59 | $54 | $743 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
54 | $76 | $1,576 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
51 | $105 | $1,784 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
40 | $87 | $1,304 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
39 | $50 | $649 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $10 | $87 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
33 | $81 | $1,594 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
32 | $87 | $1,371 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
28 | $203 | $3,603 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
28 | $64 | $1,485 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
27 | $86 | $709 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
25 | $40 | $641 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
20 | $59 | $428 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
18 | $45 | $394 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
16 | $56 | $1,227 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
15 | $155 | $2,754 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,445
Total received (2018-2024)
Avg $492/year across 7 years
Top 37% in GA for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
164
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,930 (85.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$516 (15.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$353
2023
$160
2022
$354
2021
$1,242
2020
$459
2019
$319
2018
$559
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$73
PFIZER INC.
$66
SCILEX PHARMACEUTICALS INC.
$38
Abbott Laboratories
$36
ConvaTec Inc.
$28
SI-BONE, INC.
$23
Avanos Medical
$23
Forte Bio-Pharma LLC
$23
Medtronic, Inc.
$22
Collegium Pharmaceutical, Inc.
$19
Top 3 companies account for 50.4% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$538
Abbott Laboratories
$281
Medtronic USA, Inc.
$249
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$220
Amgen Inc.
$215
Supernus Pharmaceuticals, Inc.
$189
AbbVie Inc.
$185
ABBVIE INC.
$161
PFIZER INC.
$156
Biohaven Pharmaceuticals, Inc.
$119
Daiichi Sankyo Inc.
$75
Novartis Pharmaceuticals Corporation
$69
Biohaven Pharmaceutical Holding Company Ltd.
$66
RedHill Biopharma Inc.
$62
Collegium Pharmaceutical, Inc.
$58
Allergan, Inc.
$51
Eisai Inc.
$48
ARBOR PHARMACEUTICALS, INC.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Lilly USA, LLC
$46
Boston Scientific Corporation
$41
GRT US Holding, Inc.
$38
SCILEX PHARMACEUTICALS INC.
$38
Teva Pharmaceuticals USA, Inc.
$37
Almatica Pharma LLC
$32
ConvaTec Inc.
$28
ASSERTIO THERAPEUTICS, Inc.
$27
Purdue Pharma L.P.
$24
SI-BONE, INC.
$23
Avanos Medical
$23
Forte Bio-Pharma LLC
$23
Scilex Pharmaceuticals Inc.
$21
Shionogi Inc
$19
Amneal Pharmaceuticals LLC
$19
Baudax Bio Inc.
$19
Orthogenrx Inc.
$18
AstraZeneca Pharmaceuticals LP
$17
Masimo Corporation
$17
Nuvectra Corporation
$15
IBSA Pharma Inc.
$15
SPR Therapeutics, Inc
$14
Electronic Waveform Lab, Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Stimwave Technologies Incorporated
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · AQUACEL AG+ EXTRA · Accurian · Aimovig · Algovita · Amitiza · BELSOMRA · BOTOX · CFNS StimQ Peripheral Nerve StimulatorSystem · COMIRNATY · Cambia · Dayvigo · EMGALITY · ETERNA · GENERAL PAIN MANAGEMENT · GENERATOR · GenVisc 850 · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · LICART · LYRICA · LYVISPAH · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NURTEC ODT · ORILISSA · PAXLOVID · PROCLAIM · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SCS IPGs · SPECIFY · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SYMPROIC · Symproic · TROKENDI XR · UBRELVY · VRAYLAR · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicine physicians within 10 mi
21
Per 100K population
2.7
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mefferd is a clinical cardiology specialist, with above-average Medicare volume (top 26% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mefferd experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mefferd performed 875 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mefferd receive payments from pharmaceutical companies?
Yes. Dr. Mefferd received a total of $3,445 from 45 companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mefferd's costs compare to other pain medicine physicians in Marietta?
Dr. Mefferd's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mefferd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Marietta
Browse pain medicine physicians in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in GA
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in GA
Which GA pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology